Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 12.20% | 147.00 | 0.0% | $2706.27m | |
| BNGO | BioNano Genomics, Inc. | 28.37% | 12.58 | 0.0% | $2680.39m | |
| GILD | Gilead Sciences, Inc. | 1.82% | 68.16 | 1.0% | $679.44m | |
| AMGN | Amgen, Inc. | 1.42% | 257.10 | 1.3% | $584.68m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.94% | 548.20 | 2.7% | $502.24m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.00% | 161.32 | 2.0% | $478.99m | |
| CRSP | CRISPR Therapeutics AG | -3.85% | 181.24 | 0.6% | $478.16m | |
| ILMN | Illumina, Inc. | 3.63% | 421.00 | 3.5% | $442.75m | |
| NVAX | Novavax, Inc. | 3.53% | 131.46 | 92.9% | $427.52m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.57% | 241.31 | 1.9% | $385.00m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.17% | 96.11 | 13.8% | $366.91m | |
| BIIB | Biogen, Inc. | 2.26% | 275.54 | 1.7% | $334.24m | |
| BNTX | BioNTech SE | 2.00% | 110.61 | 0.0% | $314.96m | |
| EXAS | EXACT Sciences Corp. | 2.62% | 153.93 | 19.6% | $267.92m | |
| PACB | Pacific Biosciences of California, Inc. | -3.93% | 35.95 | 7.4% | $219.94m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The firm provides its service through Iomab-B, which is studied in the ongoing pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning. The company was founded in 2002 and is headquartered in New York, NY.